Clinical Trial Update: Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial evaluated the use of amlodipine to prevent and treat iron overload in patients with thalassemia major; the study has completed Phases 2 and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Drugs mentioned

• Amlodipine (amlodipine)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Thalassemia Major | Phase 2, Phase 3 | Status: COMPLETED